Kishore Mulpuri MBBS, MS, MHSc

Dr. Mulpuri completed his medical and orthopaedic training at Kasturba Medical College, Manipal University in India and went on to pursue orthopedic fellowships at the Women’s and Children’s Hospital in Adelaide, Australia and the Melbourne Orthopedic Group and Royal Children's Hospital in Melbourne, Australia.
He subsequently moved to Vancouver, BC and completed a clinical research fellowship in orthopedics at BC Children's Hospital and a MHSc in Epidemiology at the University of British Columbia. He is now a Pediatric Orthopaedic Surgeon at BC Children's Hospital and an Associate Professor in the Division of Pediatric Orthopaedics under the Department of Orthopaedics at the University of Columbia.

His clinical practice and research interests have a major focus on the pediatric hip and cerebral palsy. He regularly treats patients with a wide range of conditions including but not limited to: Developmental Dysplasia of the Hip, Cerebral Palsy, Legg-Calve-Perthes disease, osteogenesis imperfecta , slipped capital femoral epiphysis and trauma. He is the Research Director of the International Hip Dysplasia Institute and currently holds the medical lead position for the Child Health BC Hip Surveillance Program for Children with Cerebral Palsy.

He also is Co-Lead for the Evidence to Innovation Theme at CFRI. He is the Founding President of the Canadian Pediatric Orthopaedic Group, which facilitates the academic and scientific exchange of thoughts and ideas between Canadian pediatric orthopaedic surgeons and creates invaluable opportunities for educational activities and collaborative research across Canada.

In addition, he leads the Bone Health & Mobility Research Team at BC Children’s Hospital and currently acts as Principal Investigator or Co-Investigator on various local and international multi-centre research studies. He is regularly involved with the development of new clinical practice guidelines, most recently chairing the work group that developed the guidelines for non-operative treatment and management of DDH.